Technology News and Research

RSS

Stanford Hospital installs high-definition monitors to enhance patient care

When a patient checks in to Stanford Hospital from now on, the room wall will have an extra special something. Most hospitals have had televisions in patient rooms for decades. But few now have what Stanford offers its patients on new, 26-inch high definition monitors

21 Aug 2010

OMICS recommends three-step plan for sustainable advancement and innovation

The U.S. needs a comprehensive and transformational policy for the 21st century to ensure that it remains competitive in the global science and technology arena, according to a provocative opinion piece in the latest issue of OMICS, A Journal of Integrative Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

21 Aug 2010

Elsevier Health Sciences and India's medical library consortium Helinet announce agreement

Elsevier Health Sciences and Helinet, India's premier medical library consortium for e-resources, have announced an agreement that will provide all medical students at Helinet's medical colleges with access to leading international and local medical content through Elsevier's electronic platforms: ScienceDirect(R) and MD Consult(R).

21 Aug 2010

Experts explore factors contributing to global nurse faculty migration

Twenty-one experts from 12 countries convened near Geneva, Switzerland, in late June to explore current patterns, types, and causal and contributing factors of global nurse faculty migration, a phenomenon where nursing faculty leave their country of origin to work elsewhere.

21 Aug 2010

mBeach Software issues stockholder update for skin cancer diagnostic solutions

mBeach Software Inc. today issued a stockholder update on the growing market for skin cancer diagnostic solutions. These market developments represent significant opportunities for the wholly owned subsidiary, Skin Cancer Scanning Ltd. ("SCS") to grow the company and become a leading industry player.

21 Aug 2010

HHS unveils $1.9B strategy to better prepare for biological threats

"Acknowledging that the development of medical countermeasures against bioterrorism threats and pandemic flu is lagging, [U.S.] federal authorities Thursday announced a $1.9 billion makeover of the system for identifying and manufacturing drugs and vaccines for public-health emergencies," Tribune Company/Seattle Times reports.

21 Aug 2010

Melanoma Research Alliance announces grant to support six research programs

The Melanoma Research Alliance today announced $5.2 million in grants to support six multidisciplinary teams pursuing innovative, translational research approaches designed to benefit melanoma patients.

21 Aug 2010

Center for Health Sciences to offer certificate program in Phlebotomy

Beginning in October, the Graduate School's new Center for Health Sciences will offer a Medical Laboratory Technician, Associate of Applied Science degree and a certificate program in Phlebotomy. The first of many programs to be offered, both curricula provide a combination of coursework and clinical experience with strong emphasis on employability skills such as problem solving, effective communication, professional conduct, and information and technology literacy.

21 Aug 2010

Researchers develop tiny color-changing sensor molecules

A new approach to building an "artificial nose" using fluorescent compounds and DNA could accelerate the use of sniffing sensors into the realm of mass production and widespread use, say Stanford chemists. If their method lives up to its promise, it could one day detect everything from incipiently souring milk to high explosives.

21 Aug 2010

USPTO to allow patent for Advaxis’s new vaccine technology

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has been notified that the US Patent and Trademark Office (USPTO) will allow a patent issuance of its application No. 11/785,249 entitled "Antibiotic Resistance Free Vaccines and Methods for Constructing and Using Same."

21 Aug 2010

ETC Biomedical Systems receives FDA 510-k clearance for computer hyperbaric oxygen control system

Environmental Tectonics Corporation's Biomedical Systems, a worldwide leader in the development, manufacture of computerized monoplace hyperbaric chambers, today confirmed that it has received FDA 510-k clearance for O.S.C.A.R. ™. O.S.C.A.R. ™ is an acronym for "Operating System for Control And Recording." This computerized system is configured as a stand–alone unit that will operate, control and record whole-body hyperbaric oxygen therapy treatments.

21 Aug 2010

ActiveCare announces capital raise commitment, balance sheet restructuring

ActiveCare, Inc., a biotelematic technology company that specializes in products and services that help seniors manage and control their health and wellbeing while reducing overall costs to the healthcare industry, announced a capital raise commitment and balance sheet restructuring.

21 Aug 2010

Anchor Therapeutics announces initial closing of $10 million Series B financing

Anchor Therapeutics today announced an initial closing of $10 million in a Series B financing. The investment is being led by current investors TVM Capital, HealthCare Ventures and the Novartis Option Fund. The company is in continuing discussions with additional investors interested in joining the Series B. Anchor Therapeutics is focused on developing peptide drug candidates, called pepducins, that modulate G protein coupled receptors (GPCRs), particularly those historically difficult to target using standard pharmaceutical approaches.

20 Aug 2010

Tips for management of COPD

What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.

20 Aug 2010

Cyprotex launches new in vitro toxicology service

Cyprotex PLC, the preclinical ADME Tox services company, today announces the launch of its new in vitro toxicology service, branded as Cyprotox(R). Supporting the new service is an additional 90 square metres of laboratory space at Cyprotex's Macclesfield, UK facility housing the latest technology in multi-parametric automated fluorescent imaging and cellular analysis. This gives Cyprotex's Macclesfield site the same in vitro toxicology capabilities as those of Apredica (Watertown, MA, USA), which Cyprotex acquired on 6 August 2010.

From Thermo Fisher Scientific Inc. 20 Aug 2010

NSF issues award to develop techniques for analyzing children's behavior

A team led by the Georgia Institute of Technology has received a $10 million "Expeditions in Computing" award from the National Science Foundation (NSF) to develop novel computing techniques for measuring and analyzing the behavior of children.

20 Aug 2010

Statoil ASA launches new ear plug to alleviate noise-induced hearing impairment

Some 600 cases of noise-induced hearing impairment are reported by the Norwegian petroleum industry every year. A new, intelligent earplug is now set to alleviate the problem.

20 Aug 2010

Cell-depleted lung used as natural growth matrix for generating new rat lung from embryonic stem cells

The first successful report of using cell-depleted lung as a natural growth matrix for generating new rat lung from embryonic stem cells is presented in a breakthrough article in Tissue Engineering, Part A, a peer-reviewed journal published by Mary Ann Liebert, Inc..

20 Aug 2010

Experts discuss role of technology and innovation in healthcare industry

Leaders from healthcare, technology companies and academia will meet on Tuesday, Aug. 24, for a day-long session in the Chippewa Valley technology corridor. Participants will discuss how the use of technology and innovation can help overcome some of the biggest challenges facing the healthcare industry.

20 Aug 2010

Cerulean Pharma to assemble scientific experts at ACS National Meeting symposium

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced it will assemble a group of leading scientific experts at the American Chemical Society's ("ACS") 240th National Meeting & Exposition for a three-day thought leadership summit on the advancement of nanotechnology in the pharmaceutical and diagnostic industries.

20 Aug 2010